CBD, Phytocannabinoids, and Breast Cancer. What We Know.

Recent studies suggest that CBD may have potential as an anticancer agent in breast cancer treatment. CBD may also play a role in preventing breast cancer growth and stopping breast cancer cells from spreading to other areas of the body.

Join Dr. Dwight McKee, MD and SatiMedUSA founder Chris Conway as they discuss the latest research into the benefits of incorporating CBD and other Phytocannabinoids as part of a comprehensive approach to breast cancer care, including triple-negative breast cancer.

Our discussion included audience Q&A.

Presented by:

Dwight McKee, MD

Dwight L. McKee, MD, is board certified in medical oncology, hematology, nutrition, and integrative and holistic medicine. He has specialty training in hematology and oncology, and spent two years in immunology research. Before his internal medicine residency, Dr. McKee worked with people with cancer in the context of practicing complementary medicine with an emphasis on nutritional and mind-body medicine for 12 years.

​Dr. McKee is at the forefront of the application of integrative medicine to cancer care. He brings a comprehensive perspective to the practice of oncology and hematology, and co-authored a textbook on herb, nutrient and drug interactions in 2008. He recently co-authored After Cancer Care: The Definitive Self-Care Guide to Getting and Staying Well for Patients after Cancer and edited the Cancer Strategies Journal from 2011 to 2014.

Stay in the Know!